Category: Legal Action

Update: HPV vaccines and the Supreme Court of India#HPV#Vaccines#Android

jv Leave a comment

 By Norma Erickson

January 2013, the government of India was ordered by their Supreme Court to file an answer to allegations put forth in a petition filed on behalf of Gramya Resource Centre for Women from Andhra Pradesh. This petition challenged the licensing of Gardasil and Cervarix for use in the private sector as well as attempts to introduce HPV vaccines for use in the public sector. The petition implicated the Drugs Controller for having licensed the vaccines without adequate research on safety and efficacy;  the Health Ministry for not carrying out an enquiry into licensing of these vaccines as ordered by the Parliamentary Standing Committee on Health and Family Welfare in April 2010 and not taking any action on the report of the internal enquiry committee despite all alleged irregularities associated with the PATH project being confirmed.

October 2014, India’s Supreme Court Justices issued instructions for all petitioners and respondents in the ongoing case against to either serve the opposition with copies of affidavits filed and/or file any affidavits and rejoinder affidavits pertinent to the case within the next four weeks. The matter was then set for what was supposed to be a final hearing on January 13, 2015.

When the ’final’ hearing date arrived, several respondents had still not complied with these instructions. At least one of them went so far as to hold their two-and-a-half-foot tall affidavit for presentation to the Court on  January 13th. The Honorable Supreme Court Justices did not seem to be amused.

After hearing the evidence presented on January 13th, Justices Dipak Misra and Prafulla C. Pant issued an order reminding all participants of concerns raised in a prior hearing on 12 August 2014. Those concerns are as follows:

  • Did the Drugs Controller of India and the ICMR (Indian Council on Medical Research) follow proper protocol for the introduction of HPV vaccines prior to the use of said vaccines in the demonstration projects in India?
  • What actions were taken after the submission of the Parliamentary Committee’s 72nd report on August 30, 2014?
  • What were the reasons for choosing certain places in Gujarat and Andhra Pradesh for the HPV vaccine demonstration projects?
  • What actually caused the deaths and other ailments experienced after HPV vaccine administration in said demonstration projects?
  • What steps were taken to monitor the safety of HPV vaccines by the Union of India and the State Governments who have an equal role in guarding the health of the nation?
  • Was proper consent given by the parents/guardians of all girls who were administered HPV vaccines, as the Justices been apprised?
  • What protocol is required to be observed/followed when this type of vaccination program is conducted?

The Honorable Supreme Court Justices deemed it appropriate to grant permission for the State of Gujarat, State of Andhra Pradesh, and State of Telangana to be added as parties to the current case.

The Justices also agreed to M/S Glaxosmithkline Asia Pvt. Ltd. and MSD Pharmaceuticals Pvt. Ltd., the companies responsible for manufacturing HPV vaccines, being served as respondents in the proceedings.

Justices Misra and Pant granted permission for the attorneys representing the petitioners to serve papers on the concerned Ethics Committees of all three States involved in the HPV demonstration projects.

In view of the fact that the above mentioned concerns had still not been adequately addressed, some respondents had failed to appear for prior hearings, and others had ignored requests for information or failed to submit affidavits in a timely manner the Justices included the following statements in the current order:

  • This Court hopes and trust(s) that on the next date of hearing, the Standing Counsel of all the States shall remain present and argue the matter.
  • The Union of India shall direct its competent authority to produce the file by which the Drugs Controller General of India approved HPV vaccines for use along with any other relevant documents to the Court and the Counsellors for the Petitioners in this case.
  • Learned Counsel for the Union of India shall apprise this Court what steps have been taken to comply with the recommendations put forth in the Parliamentary Committee’s Report on HPV vaccine demonstration projects in India.
  • Counsel for the State shall file their counter-affidavits within a period of four weeks.
  • The Union of India shall file their counter-affidavit (case #921/2013) within four weeks. Rejoinder affidavit, if any, within two weeks therefrom.
  • By the same time, rejoinder affidavit to the counter-affidavit filed by PATH International to be filed.
  • The Advocate for ICMR shall produce the file dealing with HPV vaccines by the next date.
  • Regarding the ’concept of consent’ and the resultant deaths: it has been submitted that though innovative explanations have been given stating that some girls in the States of Gujarat and Telangana expired due to snake bite and fever, in actuality, it is due to the administration of vaccinations.
  • It was noted that though HPV vaccines were administered for the purpose of experimentation, there is no data with regard to the adverse effects faced by the young girls.
  • Counsel for the Union of India, the State of Gujarat, and the State of Telangana shall state by way of affidavit what the procedure and protocols are to be followed while obtaining informed consent. The stand taken by the Union of India and the States shall be clear and in consonance with law, for the affidavit is not expected to be filed in contravention of that has been envisaged in law.
  • The present public interest litigation has to be perceived from the point of view of rectification and caution for the future.
  • The ’caution’ would convey what steps have to be taken in the future so that this kind of grievances do not arise.

In conclusion, the Supreme Court order states:

Learned counsel appearing for the Union of India and the States of Gujarat and Telangana shall file their respective affidavits keeping in view the directions given herein-above. To elucidate, the affidavit filed by the Union of India shall contain explicitly (i) what steps they intend to take on the basis of the report given by the Parliamentary Standing Committee, (ii) what is the procedure to be followed for the purposes of consent and what steps are required to be taken to find out the sufferings, if any, by the persons who were vaccinated, and (iii) the liability of compensation, if any, to be paid and whose liability it would be.

Justices set the next hearing date for April 21, 2015.

 

References:

India: HPV vaccines Gardasil and Cervarix make it to the Supreme Court

India: Supreme Court HPV Vaccine Controversy Continues

Original Supreme Court Documentation, go to this link – http://courtnic.nic.in/supremecourt/casestatus_new/caseno_new_alt.asp then select “Writ Petition (civil)” as the case type; 558 as the case number; and 2012 as the year. Then click submit. Follow links from there to access original documents.

 Continue to the Article Here

This article in it’s entirety is compliments of www.sanevax.org

Judges demand answers after children die in controversial cancer vaccine trial in India#cdcwhistleblower#HearThisWell#Vaccines

jv Leave a comment

There have been over 37,000. adverse events and 214 deaths from the Gardasil/Cervarix vaccines with no evidence of any benefit from the vaccine.  These figures are off of the November 2014 VAERS report and estimated to be only 1-10% of actual cases.  

By GETHIN CHAMBERLAIN IN INDORE, INDIA,

  •  Tribal girls were given shots of cervical cancer vaccines during trial
  • Children given Merck’s Gardasil and Cervarix vaccines
  • Petitioners also asked judges to investigate trials of new drug Gardasil 9
  • Drug has allegedly caused side-effects in children as young as nine
  • Investigation claims children were used as unwitting human guinea pigs
  • Supreme Court has given the government one month to provide answers

Judges in India’s Supreme Court have demanded answers after children died during a controversial cervical cancer vaccine trial.

Young tribal girls received shots of pharmaceutical company Merck’s Gardasil vaccine and Cervarix, manufactured by GlaxoSmithKline.

The vaccines are given to girls as young as nine in many countries – including the UK and the US – to protect against the human papilloma virus, one of the major causes of cervical cancer.

But the Indian court yesterday heard a challenge by campaigners who claim the study – funded by the Bill & Melinda Gates Foundation – failed to obtain the informed consent of the children or their parents.

They say that a ‘study’ carried out for the foundation by a US organisation was in fact an illegal drugs trial.

Continue to the Article Here

http://www.dailymail.co.uk/

My list of peer reviewed vaccine research#cdcwhistleblower#Family#Pregnancy

jv Leave a comment

 by the refurbished rogue

This list is just a thrown together list and is pretty helter skelter..but, there are a lot of links to lead you down the research path if you are searching. There are are so many, many, many more out there that haven’t made it to this list. They sit and wait for me to find them..i better get to looking.. May our truth digging be successful!

Hypothesis: conjugate vaccines may predispose children to autism spectrum disorders.

the potential effects of conjugate vaccines on neural development merit close examination. Conjugate vaccines fundamentally change the manner in which the immune systems of infants and young children function by deviating their immune responses to the targeted carbohydrate antigens from a state of hypo-responsiveness to a robust B2 B cell mediated response. This period of hypo-responsiveness to carbohydrate antigens coincides with the intense myelination process in infants and young children, and conjugate vaccines may have disrupted evolutionary forces that favored early brain development over the need to protect infants and young children from capsular bacteria…

Read the Entire Post Here

www.therefurbishedrogue.wordpress.com/

HPV Vaccines: SaneVax Message to Colombia#Family#Columbia#HPV

jv Leave a comment

By Norma Erickson

 

SaneVax-FeaturedAttorney Monica Leon Del Rio is currently representing several Colombian girls who are experiencing new medical conditions after the administration of Gardasil. She recently invited me to speak to a group of esteemed public health officials, government representatives and medical people in Colombia to explain why the SaneVax team does not support HPV vaccination programs.Just prior to the time I was to address the meeting, the international conference call was disconnected. Despite multiple attempts to re-establish the connection I was not able to speak as scheduled.

Therefore, my intended message to Colombia is as follows:

SaneVax is an international non-profit organization working with representatives in over 25 countries, all of whom are concerned about HPV vaccines. The SaneVax team believes vaccines should meet four common sense criteria prior to their inclusion in mass vaccination programs. We believe they should be scientifically proven safe, affordable, necessary and effective prior to government approval.

The SaneVax Team cannot support HPV vaccination programs for many reasons.

#1 HPV VACCINES ARE NOT PROVEN SAFE

  • There are over 80 vaccines approved for use in the United States. HPV vaccines account for nearly 25% of the entire Vaccine Adverse Event Reporting System (VAERS) database. This is particularly disturbing because the VAERS system was established in 1990 and HPV vaccines were not introduced until mid-2006.
  • VAERS reports of ADEM have increased over 1,000% since the introduction of HPV vaccines; infertility reports increased 790%, reports of blindness increased 188%, and spontaneous abortions by 270%.
  • According to documents submitted to the Supreme Court in India, when 24,000 girls were injected with HPV vaccines during ‘demonstration projects’ an estimated 5% (1200) were left with chronic health problems and/or autoimmune disorders.
  • Japan withdrew the government recommendation for the administration of HPV vaccines after only 6 weeks when reports of adverse events after Gardasil were 26 times higher than the annual flu shot; reports after Cervarix were 52 times higher than the annual flu shot. 24.9% of the adverse events reported were considered serious.
  • Denmark reports that 24% of the adverse events reported after HPV vaccinations were considered serious.
  • Italy reports adverse events after HPV vaccines at a rate of 219/100,000 – ten times higher than most other vaccines administered in Italy. The cervical cancer rate in Italy is 7.7/100,000.

#2 HPV VACCINES ARE NOT AFFORDABLE

  • HPV vaccination programs do not eliminate the need for pap screening, they simply add the price of 3 injections to already overburdened healthcare systems around the globe.
  • There is an already proven safe and effective method of controlling cervical cancer in most developed countries – pap screening and good gynecological follow-up. Countries without this practice in place would be money ahead to spend their healthcare budget developing the infrastructure to provide this type of care.
  • Cervical cancer causes 2.3 deaths/100,000 women in the United States. The cost of 3 doses of HPV vaccine for 100,000 women is an estimated $30,000,000 ($100/dose) to try and eliminate less than 3 deaths which could have been avoided with pap screening and good gynecological follow-up. How many medical professionals could be trained and/or medical facilities built with that same 30 million dollars?

#3 HPV VACCINES ARE NOT NECESSARY

  • The human papillomavirus has never been proven to cause cancer by itself. Other risk factors must also be present in order to prompt the development of cancer.
  • According to the World Health Organization, only 0.15% of all people exposed to any high-risk strain of HPV will ever develop cervical cancer. The vast majority of HPV ‘infections’ are benign and cause no medical problem whatsoever.
  • HPV type prevalence varies greatly from one region to the next. Are the HPV types targeted by current vaccines the same ones prevalent in your country?
  • There is no excuse for exposing the female population of the world to the risks involved with HPV vaccination when there is an already proven safe, affordable, necessary and effective means of controlling cervical cancer.

#4 HPV VACCINES ARE NOT PROVEN EFFECTIVE

  • According to the World Health Organization, only 1% of CIN1 progresses to the next stage, only 1.5% of CIN2 progresses. Only 12% of CIN3 lesions, which are actually considered a pre-cursor to cancer. Nevertheless, the FDA allowed the manufacturers of HPV vaccines to use these often self-reversing abnormal lesions as endpoints to judge the efficacy of their products.
  • The other endpoint used to predict efficacy was antibody titers. No one has determined what level of antibodies is necessary to prevent HPV infections. It is simply assumed that the higher the antibody titer level, the better the potential protection.
  • HPV vaccines have not been clinically proven to prevent a single case of cancer.
  • There is no guarantee that eliminating one risk factor for the development of cervical cancer will have any impact on the disease incidence or mortality rate.
  • It will take more than 20 years to determine whether or not HPV vaccines perform as advertised.
  • There is no guarantee that any suppressed oncogenic HPV type will not mutate over the next 20 years and become more dangerous.

I would respectfully submit that all of these facts should be taken into consideration when evaluating the HPV vaccination program in Colombia.

Please consider every new medical condition following HPV vaccine administration to be a potential adverse event. Thorough investigations are the only way to determine the safety profile of HPV vaccines in your country.

Please take action to protect your future generation.

Halt the current HPV vaccination program until you have determined whether or not HPV vaccines are a good addition to your cervical cancer prevention program.

You must answer the question – Are HPV vaccines Safe, Affordable, Necessary and Effective in Colombia?

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 LSaneVax-Featureda abogada Mónica León Del Rio actualmente representa a varias niñas colombianas que están experimentando nuevas afecciones médicas después de la administración de Gardasil. Ella hace poco me invitó a hablar a un grupo de funcionarios de salud pública, representantes gubernamentales y personal médico en Colombia para explicar por qué el equipo SaneVax no respalda los programas de vacunación contra el VPH.Justo antes de mi participación en la conferencia internacional, se desconectó la llamada. A pesar de múltiples intentos para restablecer la conexión no pude hacer mi presentación.

Por lo tanto, mi mensaje destinado a Colombia es el siguiente:

SaneVax es una organización internacional sin ánimo de lucro que trabaja con representantes en más de 25 países, todos los cuales están preocupados acerca de las vacunas contra el VPH. El equipo SaneVax cree que las vacunas deben cumplir con 4 criterios de sentido común antes de incluirse en los programas de vacunación masiva. Creemos que deben ser demostrados científicamente que son seguras, asequibles, necesarias y eficaces antes de ser aprobadas por el gobierno.

El Equipo SaneVax no puede apoyar los programas de vacunación contra el VPH por muchas razones.

#1 No se ha demostrado que las vacunas contra el VPH sean SEGURAS

  • Hay más de 80 vacunas aprobadas para su uso en los Estados Unidos. Las vacunas contra el VPH representan casi el 25% de toda la base de datos de Eventos Adversos de Vacunas (VAERS). Esto es especialmente preocupante porque el sistema VAERS se estableció en 1990 y vacunas contra el VPH no se introdujeron hasta mediados de 2006.
  • VAERS informa que los casos de Encefalitis Aguda Diseminada se han incrementado en un 1.000% desde la introducción de vacunas contra el VPH; los informes de infertilidad se incrementaron 790%, los casos de ceguera aumentaron 188%, y los abortos espontáneos por 270%.
  • De acuerdo con los documentos presentados a la Corte Suprema de la India, cuando 24.000 niñas fueron inyectadas con vacunas contra el VPH durante los “proyectos de demostración”, se estima que un 5% (1.200) quedaron con problemas de salud crónicos y / o trastornos autoinmunes.
  • Japón retiró la recomendación del gobierno para la administración de las vacunas contra el VPH después de sólo 6 semanas, cuando los informes de eventos adversos después de la aplicación del Gardasil eran 26 veces más altos que los de la vacuna anual contra la gripe; los informes de eventos adversos después de la aplicación de Cervarix fueron 52 veces más altos que los de la vacuna anual contra la gripe. El 24,9% de los eventos adversos informados fueron considerados graves.
  • Dinamarca informa que se consideran graves un 24% de los eventos adversos informados después de la vacunación contra el VPH.
  • Italia informa de los eventos adversos después de la aplicación de las vacunas contra el VPH a una tasa del 219/100 000 – diez veces más alta que la mayoría de las vacunas administradas en Italia. La tasa de cáncer de cuello uterino en Italia es de 7,7 / 100.000.

#2 Las vacunas contra el VPH NO SON ADSEQUIBLES

  • Los programas de vacunación contra el VPH no eliminan la necesidad de las pruebas de detección de Papanicolaou (citología vaginal), inclusive hay que añadir el precio de 3 inyecciones que se sobrecargan a los sistemas sanitarios de todo el mundo.
  • La detección mediante la prueba de citología vagina (prueba de Papanicolaou) es un método seguro y eficaz ya probado para controlar el cáncer cervical en los países más desarrollados incluyendo el buen seguimiento ginecológico.
  • El cáncer cervical provoca 2,3 muertes / 100.000 mujeres en los Estados Unidos. El costo de 3 dosis de la vacuna contra el VPH para 100.000 mujeres tiene un costo estimado de $ 30.000.000 ($ 100 / dosis) para tratar de eliminar menos de 3 muertes que podrían haberse evitado con la prueba de Papanicolaou y un buen seguimiento ginecológico. ¿Cuántos profesionales de la medicina podrían ser capacitados o cuántas instalaciones médicas se podrían construir con los mismos 30 millones de dólares?

#3 Las vacunas contra el VPH no son necesarias

  • El virus del papiloma humano nunca se ha demostrado que cause el cáncer por sí mismo. Otros factores de riesgo también deben estar presentes para facilitar el desarrollo del cáncer.
  • De acuerdo con la Organización Mundial de la Salud, sólo el 0,15% de todas las personas expuestas a cualquier cepa de alto riesgo de VPH desarrollarán cáncer cervical. La gran mayoría de los ”infecciones” por VPH son benignas y no causan ningún problema médico.
  • La prevalencia del tipo de VPH varía mucho de una región a otra. ¿Son los tipos de VPH que son el blanco de las vacunas actuales los mismos que prevalecen en su país?
  • No hay excusa para la exposición de la población femenina del mundo a los riesgos que implica la vacunación contra el VPH cuando ya hay métodos seguros, asequibles, necesarios y efectivos probados para el control del cáncer cervical.

#4 Las vacunas contra el VPH no tienen una eficacia demostrada

  • De acuerdo con la Organización Mundial de la Salud, sólo el 1% de Neoplasia Intraepitelial Cervical 1 (CIN1) avanza a la siguiente etapa CIN2 y de esta sólo el 1,5% progresa. Solo un 12% de las lesiones CIN3 son en verdad consideradas como precursoras del cáncer. Sin embargo, la FDA permitió a los fabricantes de vacunas contra el VPH utilizar estas lesiones anormales que a menudo se curan por sí mismas como criterios para juzgar la eficacia de la vacuna.
  • El otro criterio de valoración utilizado para predecir la eficacia fueron las medidas de anticuerpos. Nadie ha determinado cuál es el nivel de anticuerpos necesario para prevenir las infecciones por VPH. Simplemente se supone que el nivel más alto de anticuerpos es potencialmente mejor.
  • No se ha demostrado clínicamente que ninguna vacuna contra el VPH prevenga un solo caso de cáncer.
  • No hay garantía de que la eliminación de un factor de riesgo para el desarrollo de cáncer de cuello uterino (infección por VPH) tendrá impactos sobre la incidencia de la enfermedad o tasa de mortalidad.
  • Tardará más de 20 años para determinarse si las vacunas contra el VPH funcionan o no como se anuncia.
  • No hay garantía de que cualquier tipo de VPH oncogénico suprimido por la vacuna no va a mutar en los próximos 20 años y ser más peligroso.

Me permito pedir respetuosamente que todos estos hechos sean tenidos en cuenta al evaluar el programa de vacunación contra el VPH en Colombia.

Por favor consideren que cada nuevo caso de anormalidad médica luego de la administración de la vacuna contra el VPH puede ser un evento adverso a la misma. Las investigaciones exhaustivas son la única manera de determinar el perfil de seguridad de las vacunas contra el VPH en su país.

Por favor, tomen medidas para proteger sus generaciones futuras.

Detengan el programa de vacunación contra el VPH actual hasta que se haya determinado si las vacunas contra el VPH son una buena adición al programa de prevención de cáncer de cuello uterino.

Deben responder a la pregunta – ¿Son las vacunas contra el VPH seguras, asequibles, necesarias y eficaces en Colombia?

 

 

 

This article in it’s entirety, is compliments of www.SaneVax.org

Vaccines and Autism – Is the MMR Guilty of Causing Autism?#ASD#iBelieve#Vaccines

jv Leave a comment

by Sima Ash

Vaccines for the Greater Greed

The vaccine industry gives millions to the American Academy of Pediatrics for conferences, grants and classes – a clear conflict of interest.

Dr. Paul Offit who is very critical of those who do not vaccinate or use a different timeline from the CDC’s recommended schedule, is the Chief of Infections Disease at Children’s Hospital of Philadelphia and just happens to hold a $1.5 million research chair that is funded by Merck and holds the patent on the Rotateq vaccine – another clear conflict of interest[ii]. Dr. Paul Offit has also stated that babies can tolerate “10,000 vaccines at once”

But money and greed can play a role in vaccines. In fact the mumps portion of the MMR’s validity is being called into question. Whistleblowers claim that Merck management instructed..

Read the Entire Post Here

www.healing4soul.com